Home › Funds › Palo Alto Investors LP › BMRN

Palo Alto Investors LP position in BMRN

BIOMARIN PHARMACEUTICAL INC · Health Care

Palo Alto Investors LP reported holding 642,455 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$38.5M, representing 5.73% of its reported portfolio and ranking #5 among its reported holdings. Palo Alto Investors LP has disclosed BMRN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)642.46K sh
Reported value held$38.55M
Portfolio Weight5.73%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's BMRN position evolved

Palo Alto Investors LP first disclosed a stake in BMRN in Q3 2023 at 1,831,035 shares (US$162.0M). Across 13 filings, Palo Alto Investors LP increased the stake 0 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 642,455 shares valued at US$38.5M — a reduction of -40,322 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.83M $162.01M New
Q4 2023 1.50M $144.70M Reduce
Q1 2024 1.13M $99.09M Reduce
Q2 2024 1.13M $93.05M Hold
Q3 2024 1.09M $76.62M Reduce
Q4 2024 1.07M $70.15M Reduce
Q1 2025 991.21K $70.07M Reduce
Q2 2025 840.47K $46.20M Reduce
Q3 2025 754.01K $40.84M Reduce
Q4 2025 746.26K $44.35M Reduce
Q1 2026 685.18K $38.71M Reduce
Q2 2026 682.78K $39.07M Hold
Q3 2026 642.46K $38.55M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 27 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$430.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has Palo Alto Investors LP held BMRN?

Palo Alto Investors LP has disclosed BMRN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Palo Alto Investors LP's current position in BMRN?

As of Q3 2026, Palo Alto Investors LP holds 642.46K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $38.55M, representing 5.73% of its reported portfolio and ranking #5.

Has Palo Alto Investors LP been buying or selling BMRN?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in BMRN.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.